Haemophilia and its curative as well as preventive measures explained by Dr. Shrinath Kshirsagar, Hematologist and BMT Specialist

▴
Haemophilia is a rare disease which affects 1 in 5,000 people in India. Fortunately, medical science is coming up with advanced treatment options making the future of haemophilia management brighter, says Dr. Shrinath Kshirsagar.

Haemophilia is a medical condition in which the ability of the blood to clot is severely reduced, causing the sufferer to bleed profusely from even a slight injury. On the occasion of World Haemophilia day which falls in April, Medicircle is conducting an exclusive series on this hereditary disorder featuring eminent hematologists to spread awareness about this rare medical condition.

Dr. Shrinath Kshirsagar is a leading Hematologist in Mumbai. He is also a Hemato-Oncologist and Bone Marrow Transplant Specialist. Dr. Kshirsagar provides world-class treatment to his patients at Global Hospital which is an oncological center that runs under his leadership. He has many national and international publications to his credit.

Dr. Kshirsagar explains, “Haemophilia is one of the rare bleeding disorders, it is a single gene mutation, X-linked disorder. There is a problem in the fibrin formation and other multiple factors in the blood like protein, are absent and which disable the formation of platelet plug or fibrin clot that has the capacity to stop the bleeding. Since it is a single gene mutation disease, mostly males are commonly affected by it. 

There are two types of haemophilia. One is Haemophilia A which is caused due to the deficiency of factor VIII (8) and the other is Haemophilia B, which is caused due to deficiency of factor IX (9). The platelet plug or fibrin clot is not formed in these conditions and that is why the patient continues to bleed even in a small or trivial injury. In the Indian population, 1 in 5,000 patients suffer from this disorder. 

Haemophilia can be classified into three categories, depending upon its severity. One is mild which is when the factor levels are on the higher side, moderate when the factor levels are between 1 to 5% and severe when the factor levels are less than 1%. There is a high tendency of patients to bleed in small injury or small cuts,” says Dr. Kshirsagar.

Haemophilia is a hereditary disorder

Dr. Kshirsagar emphasizes that Haemophilia is common in males. They inherit it from the maternal side of the family. Females are the carrier of this disorder but it’s not common in them, rather the disorder gets transferred from them to their offspring. Haemophilia is caused by a mutation or change, in one of the genes. These genes are found on the X chromosome. Males have one X and one Y chromosome (XY) and females have two X chromosomes (XX). Males inherit the X chromosome from their mothers and the Y chromosome from their fathers and that is why they inherit haemophilia from their mother’s side if there is an X chromosome that has a mutation in either factor VIII (8) or factor IX (9) gene.

Managing Haemophilia

Dr. Kshirsagar mentions, “Haemophilia gets identified through incident-finding. For example, if a patient has gone to the dentist or for any small surgery and it gets observed that the bleeding is not stopping even after the small surgery, then it gets identified that the patient might have haemophilia. After haemophilia gets identified, patients should always take preventive measures, for example, if he is going cycling, he should take precautions of not getting injured by wearing a knee cap, elbow cap, helmet, etc. Also, even if he is going for small surgical procedures like going to the dentist then doctors should be informed accordingly so that further procedures can be adopted. Also, if one is suffering from severe haemophilia, he/she should have an ID card with the mention of the condition so that doctors can accordingly proceed and plan the treatment if any. One can also register at the nearest Haemophilia center. It is advisable to keep certain factors of which there is a deficiency in the body and take those factors immediately when required,” says Dr. Kshirsagar.

Curative and Preventive Measures of Haemophilia

Dr. Kshirsagar explains, “With the advancement in medical science, there are certain curative and preventive options available through which haemophilia can be managed efficiently. For example, Gene therapy is a curative measure through which defective genes get identified and changed so that the factors' production gets normal. 

Also, there were only short-acting factors available earlier. Now, we have long-acting factors available to overcome limitations in haemophilia management. There have been more advanced medications too compared to the past that helps in managing haemophilia more effectively. Future seems even brighter in the area of curative measures. As a preventive measure, genetic screening can be done and if the foetus is found to be affected by haemophilia then aborting the pregnancy to prevent complications, later on, is a measure that one can adopt,” says Dr. Kshirsagar.


(Edited by Amrita Priya)

 

Contributed By: Dr. Shrinath Kshirsagar, Hematologist and BMT Specialist
Tags : #World-Haemophilia-Day-Awareness-Series #drshrinathkshirsagar #globalhospital #bleedingdisorder #hemophilia #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026